London: General practitioners (GPs) in the UK can now begin prescribing weight loss jabs on the NHS, marking a significant shift in obesity treatment accessibility.
Starting today, around 220,000 individuals with the greatest medical need are set to receive Mounjaro, a powerful weight loss drug, during the first year of a strictly controlled rollout.
Eligibility in the initial phase is limited to those with a body mass index (BMI) over 40, coupled with at least four other obesity-related health conditions. These restrictions are aimed at prioritizing those at highest risk due to severe obesity-related complications.
Women who are pregnant, trying to conceive, or breastfeeding have been explicitly advised not to use these weight loss jabs due to potential risks.
Although an estimated 1.5 million people in the UK are already taking weight loss medications, access has been previously confined to private prescriptions or specialist medical services. The NHS rollout represents the first time such medications are being made available through routine GP services.
Workload and shortage tensions
Despite the advancement, concerns have been raised by both doctors and pharmacists. Some GPs worry about the added workload the weight loss jabs programme, will impose, while pharmacists fear supply shortages due to rising demand.
Dr. Claire Fuller of NHS England acknowledged the urgency of tackling the obesity crisis and remarked that, “We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health, and greater access to weight loss drugs will make a significant difference to the lives of those people.”
Similarly, Olivier Picard, Chair of the National Pharmacy Association, cautioned that simply prescribing medication misses the point. Picard argued for a holistic strategy that includes nutritional counseling, exercise plans, and lifestyle coaching.
Although not everyone will qualify for these drugs, those concerned about their weight should consult their healthcare provider about the range of support available on the NHS, Dr. Fuller added.
Currently, around 29 percent of the UK adult population is classified as obese, underscoring the urgency behind this initiative.
Health Secretary Wes Streeting expressed confidence in the weight loss jabs rollout and stated that, “The government is determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay.”
The rollout aligns with a broader national strategy to redefine the treatment of obesity, reduce long-term health costs, and make cutting-edge medical solutions accessible to the public health system.
MOST READ | Trump confirms strikes on Iranian Nuclear Sites; Calls for peace
